Studies have shown that starting a high-efficacy DMT like Tysabri earlier in the disease course can also lead to less ...

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...

MS patients on anti-CD20 therapies are significantly less likely to discontinue treatment than those given other DMTs, a ...

Biogen believes that some of its new drugs, Leqembi, Skyclarys and Zurzuvae, have the potential to revive long-term growth. Can Biogen achieve this goal?

High-dose vitamin D supplementation reduces disease activity in clinically isolated syndrome typical of MS, results of a ...

Following discontinuation of another MS medication associated with PML, lower PML-related mortality and morbidity have been reported in patients who were initially asymptomatic at diagnosis ...

In a cross-sectional study of 166 patients with an atypical presentation and 25 with a radiological-only presentation — none of whom would have met criteria for an MS diagnosis under previous ...

You can try different medications to treat bipolar disorder. These may carry risks, ranging from physical to mental side effects. A doctor can best guide you on safe treatment options for bipolar ...

came under fire for delaying its decision on whether the breakthrough drug beta interferon should be available to all MS sufferers on the NHS. Catherine, who had to fight for her right to have the ...

NEW YORK - TG Therapeutics, Inc. (NASDAQ: NASDAQ:TGTX) has presented data from its Phase 3 trials of BRIUMVI® (ublituximab-xiiy) for treating relapsing forms of multiple sclerosis (RMS ... an oral ...